Janssen and partners seek to develop treatments for dengue fever

08/29/2013 | Reuters

Johnson & Johnson's Janssen Pharmaceuticals agreed to team up with researchers from the University of Leuven in Belgium and the Wellcome Trust charity to develop treatments for dengue fever. The collaboration will focus on a series of compounds that have been shown to block dengue virus replication. The deal includes upfront payment as well as potential milestone fees and royalties.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ